Puma Tangible Asset Value from 2010 to 2026
| PBYI Stock | USD 6.21 -0.01 -0.16% |
Tangible Asset Value | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Review Puma Biotechnology financial statements over time to add context on performance and capital structure. Key drivers include Interest Expense of 5.8 M, Other Operating Expenses of 181.4 M or Operating Income of 39.2 M along with ratios such as Price To Sales Ratio of 1.37, Dividend Yield of 0.0 or PTB Ratio of 2.17. This view complements Puma Biotechnology Valuation and Volatility modules.
Puma | Tangible Asset Value | Build AI portfolio with Puma Stock |
Currently Active Assets on Macroaxis
More Resources for Puma Stock Analysis
A structured review of Puma Biotechnology often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Puma Biotechnology Stock. Outlined below are key reports that provide context for Puma Biotechnology Stock:Review Puma Biotechnology Correlation against competitors for Puma Biotechnology. This adds peer-relative context. For information on how to trade Puma Stock refer to our How to Trade Puma Stock guide.Analysis related to Puma Biotechnology should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Quarterly Earnings Growth -0.34 | Earnings Share 0.61 | Revenue Per Share | Quarterly Revenue Growth 0.277 | Return On Assets |
The market value of Puma Biotechnology is measured differently than book value, which reflects Puma accounting equity. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Market price can move with sentiment, cycles, and liquidity conditions, so it may drift away from fundamentals. Valuation methods compare these perspectives to frame context.
Note that Puma Biotechnology's intrinsic value and market price are different measures derived from different inputs. Analysis often considers earnings, revenue quality, fundamentals, technical signals, competition, and analyst coverage. By contrast, market price reflects the level where buyers and sellers transact.